专利检索 ap:("Novartis AG" OR "Debiopharm S.A.") AND inv:"CRABBE, Rafael" 第 1 页

1.

发明公开
NEW TREATMENTS OF HEPATITIS C VIRUS INFECTION 审中-公开
标题翻译：丙型肝炎病毒的新的治疗INFECTION-

公开(公告)号：EP2624840A1

公开(公告)日：2013-08-14

申请号：EP11763959.1

申请日：2011-10-03

申请人： Novartis AG , Debiopharm S.A.

发明人： AVILA, Claudio , CRABBE, Rafael , NAOUMOV, Nikolai

IPC分类号： A61K31/7056 , A61K38/13 , A61K38/21 , A61P31/14 , A61K45/06

CPC分类号： A61K38/13 , A61K31/7056 , A61K38/21 , A61K45/06 , A61K2300/00

摘要： The invention concerns the use of cyclophilin inhibitors in the treatment of Hepatitis C virus genotype 2 or 3 infection.

2.

发明公开
NON-IMMUNOSUPPRESSIVE CYCLOSPORIN FOR TREATMENT OF ULLRICH CONGENITAL MUSCULAR DYSTROPHY 审中-公开
标题翻译：非免疫抑制环孢菌素于治疗巩膜接触失张力肌

公开(公告)号：EP2124992A2

公开(公告)日：2009-12-02

申请号：EP08702176.2

申请日：2008-01-03

申请人： DEBIOPHARM S.A.

发明人： BERNARDI, Paolo , VUAGNIAUX, Grégoire , CRABBE, Rafael

IPC分类号： A61K38/08 , A61P21/00

CPC分类号： A61K38/13 , A61P21/00

摘要： The present invention relates to the use of a nonimmunosuppressive cyclosporin A derivative for reducing mitochondrial dysfunction and the rate of apoptosis of muscle cells of patients diagnosed with Ullrich congenital muscular dystrophy or Bethlem myopathy.